Inhibition of CCR2 attenuates NLRP3-dependent pyroptosis after myocardial ischaemia–reperfusion in rats via the NF-kB pathway
International Immunopharmacology · 2025-01 · 145 · 113803
DOI: 10.1016/j.intimp.2024.113803 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Yun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China; Department of Electroca…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Myocardial Reperfusion Injury, Rats, Sprague-Dawley. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Anhui Medical University.
Abstract (Originalsprache)
Myocardial infarction (MI) is a leading cause of mortality worldwide, contributing significantly to long-term cardiac dysfunction and heart failure. Effective therapeutic strategies are urgently needed to mitigate the extensive damage caused by MI and subsequent ischemia-reperfusion (I/R) injury. This study investigates the role of the Chemokine receptor 2 (CCR2) in regulating NLRP3-dependent cardiomyocyte pyroptosis following myocardial ischemia-reperfusion (MIR), elucidating its molecular mechanisms. A myocardial ischemia-reperfusion model was established using 124 Sprague-Dawley rats by ligating the left coronary artery, inducing 30 min of ischemia. Following ischemia, RS504393, a selective CCR2 antagonist, was administered intraperitoneally one hour after reperfusion. To further explore the underlying mechanisms, the NF-κB pathway agonist Phorbol 12-myristate 13-acetate (PMA) was administered 1 h post-MIR. The results showed a marked increase in CCR2 expression in the heart, peaking on the first day of reperfusion. Treatment with RS504393 significantly improved short-term cardiac function and reduced myocardial infarction size, decreased myocardial pyroptosis and suppressed the expression of NLRP3, GSDMD, Caspase-1, IL-1β, and IL-18 through inhibition of the NF-κB signaling pathway. This effect was reversed with the administration of PMA. In summary, the inhibition of CCR2 shows potential in mitigating myocardial injury following MIR by modulating the NF-κB signaling pathway. These findings highlight CCR2 as a promising therapeutic target for myocardial ischemia-reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China; Department of Electrocardiography, The Second Affiliated Hospital of Anhui Medical University…
- Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China.
- Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Anhui 230001, China; Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medi…
- Department of Electrocardiography, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China.
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230001, China. Electronic address: xiejun@ahmu.edu.cn.
Förderung
- Anhui Medical University
Zitieren
APA
Wang, Y., Ge, J., Dou, M., Cheng, X., Chen, X., Ma, L., & Xie, J. (2025). Inhibition of CCR2 attenuates NLRP3-dependent pyroptosis after myocardial ischaemia–reperfusion in rats via the NF-kB pathway. International Immunopharmacology, 145, 113803. https://doi.org/10.1016/j.intimp.2024.113803
Vancouver
Wang Y, Ge J, Dou M, Cheng X, Chen X, Ma L, et al. Inhibition of CCR2 attenuates NLRP3-dependent pyroptosis after myocardial ischaemia–reperfusion in rats via the NF-kB pathway. International Immunopharmacology. 2025;145:113803. doi:10.1016/j.intimp.2024.113803
BibTeX
@article{Wang2025,
author = {Wang, Yun and Ge, Jinlong and Dou, Mengyun and Cheng, Xueying and Chen, Xinran and Ma, Lan and Xie, Jun},
title = {Inhibition of CCR2 attenuates NLRP3-dependent pyroptosis after myocardial ischaemia–reperfusion in rats via the NF-kB pathway},
journal = {International Immunopharmacology},
year = {2025},
volume = {145},
pages = {113803},
doi = {10.1016/j.intimp.2024.113803}
}
EUVIMED